IRIS Accounts Production v25.4.0.155 07474135 Board of Directors 1.4.24 31.3.25 31.3.25 Medium entities dental practice services. true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh074741352024-03-31074741352025-03-31074741352024-04-012025-03-31074741352023-03-31074741352023-04-012024-03-31074741352024-03-3107474135ns15:EnglandWales2024-04-012025-03-3107474135ns14:PoundSterling2024-04-012025-03-3107474135ns10:Director12024-04-012025-03-3107474135ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107474135ns10:MediumEntities2024-04-012025-03-3107474135ns10:Audited2024-04-012025-03-3107474135ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-3107474135ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-3107474135ns10:FullAccounts2024-04-012025-03-310747413512024-04-012025-03-3107474135ns10:OrdinaryShareClass12024-04-012025-03-3107474135ns10:Director22024-04-012025-03-3107474135ns10:Director32024-04-012025-03-3107474135ns10:Director42024-04-012025-03-3107474135ns10:RegisteredOffice2024-04-012025-03-3107474135ns5:CurrentFinancialInstruments2025-03-3107474135ns5:CurrentFinancialInstruments2024-03-3107474135ns5:Non-currentFinancialInstruments2025-03-3107474135ns5:Non-currentFinancialInstruments2024-03-3107474135ns5:ShareCapital2025-03-3107474135ns5:ShareCapital2024-03-3107474135ns5:RetainedEarningsAccumulatedLosses2025-03-3107474135ns5:RetainedEarningsAccumulatedLosses2024-03-3107474135ns5:ShareCapital2023-03-3107474135ns5:RetainedEarningsAccumulatedLosses2023-03-3107474135ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-3107474135ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-3107474135ns5:NetGoodwill2024-04-012025-03-3107474135ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-04-012025-03-3107474135ns5:PlantMachinery2024-04-012025-03-3107474135ns5:FurnitureFittings2024-04-012025-03-3107474135ns5:MotorVehicles2024-04-012025-03-3107474135ns5:ComputerEquipment2024-04-012025-03-3107474135ns5:OwnedAssets2024-04-012025-03-3107474135ns5:OwnedAssets2023-04-012024-03-3107474135ns5:NetGoodwill2023-04-012024-03-3107474135ns5:NetGoodwill2024-03-3107474135ns5:NetGoodwill2025-03-3107474135ns5:NetGoodwill2024-03-3107474135ns5:LandBuildings2024-03-3107474135ns5:PlantMachinery2024-03-3107474135ns5:FurnitureFittings2024-03-3107474135ns5:LandBuildings2024-04-012025-03-3107474135ns5:LandBuildings2025-03-3107474135ns5:PlantMachinery2025-03-3107474135ns5:FurnitureFittings2025-03-3107474135ns5:LandBuildings2024-03-3107474135ns5:PlantMachinery2024-03-3107474135ns5:FurnitureFittings2024-03-3107474135ns5:MotorVehicles2024-03-3107474135ns5:ComputerEquipment2024-03-3107474135ns5:MotorVehicles2025-03-3107474135ns5:ComputerEquipment2025-03-3107474135ns5:MotorVehicles2024-03-3107474135ns5:ComputerEquipment2024-03-3107474135ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107474135ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3107474135ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-3107474135ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-3107474135ns5:WithinOneYear2025-03-3107474135ns5:WithinOneYear2024-03-3107474135ns5:BetweenOneFiveYears2025-03-3107474135ns5:BetweenOneFiveYears2024-03-3107474135ns5:AllPeriods2025-03-3107474135ns5:AllPeriods2024-03-3107474135ns5:Secured2025-03-3107474135ns5:Secured2024-03-3107474135ns5:AcceleratedTaxDepreciationDeferredTax2025-03-3107474135ns5:AcceleratedTaxDepreciationDeferredTax2024-03-3107474135ns5:DeferredTaxation2024-03-3107474135ns5:DeferredTaxation2024-04-012025-03-3107474135ns5:DeferredTaxation2025-03-3107474135ns10:OrdinaryShareClass12025-03-3107474135ns5:RetainedEarningsAccumulatedLosses2024-03-3107474135ns10:Director112024-03-3107474135ns10:Director112023-03-3107474135ns10:Director112024-04-012025-03-3107474135ns10:Director112023-04-012024-03-3107474135ns10:Director112025-03-3107474135ns10:Director112024-03-31
REGISTERED NUMBER: 07474135 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 31 March 2025

for

Nationwide Healthcare Providers Limited

Nationwide Healthcare Providers Limited (Registered number: 07474135)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 4

Income Statement 8

Balance Sheet 9

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 14


Nationwide Healthcare Providers Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: J Ahmad
M C Hallen
A K V Alfredsson
M Q Shiekh





REGISTERED OFFICE: New Brook House 385 Alfreton Road
2nd Floor
Nottingham
NG7 5LR





REGISTERED NUMBER: 07474135 (England and Wales)





AUDITORS: Duncan & Toplis Audit Limited
Statutory Auditor
Park House
37 Clarence Street
Leicester
Leicestershire
LE1 3RW

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Strategic Report
for the Year Ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

REVIEW OF BUSINESS
The directors are pleased with the results for the year and are satisfied with the position at the year end. The business has generated increased profit in the financial year through investment in additional surgeries.

PRINCIPAL RISKS AND UNCERTAINTIES
The directors consider the biggest threat to the business to be changes to recruitment resulting from Brexit. These changes could impact on the quantum of delivery of dental services.

KEY PERFORMANCE INDICATORS
The directors assess the performance of the business using the following financial key performance indicators: turnover, gross profit, profit before tax, cash and net assets. All of this information can be obtained from the financial statements.

FUTURE DEVELOPMENTS
The directors are confident that the demand for high quality dental services will continue and they are confident that they are well placed to deliver this service.

ON BEHALF OF THE BOARD:





J Ahmad - Director


19 December 2025

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Report of the Directors
for the Year Ended 31 March 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

DIVIDENDS
No dividends will be distributed for the year ended 31 March 2025.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

J Ahmad
M C Hallen
A K V Alfredsson

Other changes in directors holding office are as follows:

M Q Shiekh was appointed as a director after 31 March 2025 but prior to the date of this report.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

ON BEHALF OF THE BOARD:





J Ahmad - Director


19 December 2025

Report of the Independent Auditors to the Members of
Nationwide Healthcare Providers Limited

Opinion
We have audited the financial statements of Nationwide Healthcare Providers Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Nationwide Healthcare Providers Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Report of the Independent Auditors to the Members of
Nationwide Healthcare Providers Limited


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Extent to which the audit was considered capable of detecting irregularities, including fraud

The capability to detect irregularities is based on the auditor identifying and assessing the risks of material misstatement of the financial statements, whether due to fraud or error, and then designing and performing audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.

a) Identifying and assessing potential risks related to irregularities

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, the following approach was taken:

- Understanding the nature of the industry and sector, control environment and business performance;
- Consideration of the results of our enquiries of management and those charged with governance
about their own identification and assessment of the risks of irregularities;
- Understanding the company's policies and procedures on compliance with laws and regulations and
management of fraud risk, including documentation of instances of non-compliance of laws and
regulations and instances of actual, suspected or alleged fraud;
- Consideration of matters discussed among the audit engagement team regarding how and where
fraud might occur in the financial statements and any potential indicators of fraud;
- Understanding the legal and regulatory frameworks that the company operates in through enquiry of
management and those charged with governance and understanding the company's industry and
sector. The key laws and regulations that were considered to have an effect on material amounts and
disclosures in the financial statements included the Companies Act and tax legislation.

b) Audit response to risks identified

Based on this understanding, the following audit procedures were designed and performed to respond to the risks identified:

- Reviewing the financial statement disclosures and testing to supporting documentation to assess
compliance with applicable laws and regulations described as having a direct effect on the financial
statement;
- Enquiring of management, those charged with governance and, where applicable, the company's
solicitors concerning actual and potential litigation and claims;
- Performing analytical procedures to identify any unusual or unexpected relationships that may
indicate risks of material misstatement due to fraud;
- Reviewing minutes of meetings of those charged with governance and, where applicable,
correspondence with regulators;
- Performing audit work over the risk of management override of controls, including testing of journal
entries and other adjustments for appropriateness and evaluating the business rationale of significant
transactions outside the normal course of business;
- Communication of potential fraud risks to all engagement team members and remaining alert to any
indications of fraud or non-compliance with laws and regulations throughout the audit.


Report of the Independent Auditors to the Members of
Nationwide Healthcare Providers Limited

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Peter J Morris FCA (Senior Statutory Auditor)
for and on behalf of Duncan & Toplis Audit Limited
Statutory Auditor
Park House
37 Clarence Street
Leicester
Leicestershire
LE1 3RW

22 December 2025

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Income Statement
for the Year Ended 31 March 2025

31.3.25 31.3.24
Notes £    £   

TURNOVER 30,207,997 20,447,836

Cost of sales (14,339,282 ) (10,741,953 )
GROSS PROFIT 15,868,715 9,705,883

Administrative expenses (8,781,867 ) (6,535,917 )
7,086,848 3,169,966

Other operating income 36,820 2,340
OPERATING PROFIT 4 7,123,668 3,172,306

Interest receivable and similar income 68,647 4,902
7,192,315 3,177,208

Interest payable and similar expenses 5 (130,520 ) (67,501 )
PROFIT BEFORE TAXATION 7,061,795 3,109,707

Tax on profit 6 (1,816,569 ) (848,334 )
PROFIT FOR THE FINANCIAL YEAR 5,245,226 2,261,373

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £   
FIXED ASSETS
Intangible assets 7 605,594 498,559
Tangible assets 8 7,582,898 6,611,860
8,188,492 7,110,419

CURRENT ASSETS
Stocks 9 95,343 95,343
Debtors 10 30,112,919 25,147,713
Cash at bank and in hand 1,140,002 85,724
31,348,264 25,328,780
CREDITORS
Amounts falling due within one year 11 (7,427,319 ) (5,547,405 )
NET CURRENT ASSETS 23,920,945 19,781,375
TOTAL ASSETS LESS CURRENT
LIABILITIES

32,109,437

26,891,794

CREDITORS
Amounts falling due after more than one
year

12

(1,692,871

)

(1,828,056

)

PROVISIONS FOR LIABILITIES 16 (323,784 ) (216,182 )
NET ASSETS 30,092,782 24,847,556

CAPITAL AND RESERVES
Called up share capital 17 10,000,000 10,000,000
Retained earnings 18 20,092,782 14,847,556
SHAREHOLDERS' FUNDS 30,092,782 24,847,556

The financial statements were approved by the Board of Directors and authorised for issue on 19 December 2025 and were signed on its behalf by:





J Ahmad - Director


Nationwide Healthcare Providers Limited (Registered number: 07474135)

Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 April 2023 10,000,000 12,586,183 22,586,183

Changes in equity
Total comprehensive income - 2,261,373 2,261,373
Balance at 31 March 2024 10,000,000 14,847,556 24,847,556

Changes in equity
Total comprehensive income - 5,245,226 5,245,226
Balance at 31 March 2025 10,000,000 20,092,782 30,092,782

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Cash Flow Statement
for the Year Ended 31 March 2025

31.3.25 31.3.24
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 3,106,796 1,802,826
Interest paid (130,520 ) (67,501 )
Tax paid (700,000 ) (1,079,903 )
Net cash from operating activities 2,276,276 655,422

Cash flows from investing activities
Purchase of intangible fixed assets (156,891 ) (498,559 )
Purchase of tangible fixed assets (1,404,593 ) (2,366,955 )
Sale of tangible fixed assets - 573,685
Interest received 68,647 4,902
Net cash from investing activities (1,492,837 ) (2,286,927 )

Cash flows from financing activities
Loan repayments in year (189,407 ) (91,662 )
Amount introduced by directors 471,013 -
Amount withdrawn by directors - (564,738 )
Net cash from financing activities 281,606 (656,400 )

Increase/(decrease) in cash and cash equivalents 1,065,045 (2,287,905 )
Cash and cash equivalents at
beginning of year

2

74,957

2,362,862

Cash and cash equivalents at end of
year

2

1,140,002

74,957

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Cash Flow Statement
for the Year Ended 31 March 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS

31.3.25 31.3.24
£    £   
Profit before taxation 7,061,795 3,109,707
Depreciation charges 483,411 355,593
Finance costs 130,520 67,501
Finance income (68,647 ) (4,902 )
7,607,079 3,527,899
Increase in stocks - (20,343 )
Increase in trade and other debtors (5,436,219 ) (3,094,057 )
Increase in trade and other creditors 935,936 1,389,327
Cash generated from operations 3,106,796 1,802,826

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025
31.3.25 1.4.24
£    £   
Cash and cash equivalents 1,140,002 85,724
Bank overdrafts - (10,767 )
1,140,002 74,957
Year ended 31 March 2024
31.3.24 1.4.23
£    £   
Cash and cash equivalents 85,724 2,362,862
Bank overdrafts (10,767 ) -
74,957 2,362,862


Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Cash Flow Statement
for the Year Ended 31 March 2025

3. ANALYSIS OF CHANGES IN NET DEBT

At 1.4.24 Cash flow At 31.3.25
£    £    £   
Net cash
Cash at bank and in hand 85,724 1,054,278 1,140,002
Bank overdrafts (10,767 ) 10,767 -
74,957 1,065,045 1,140,002
Debt
Debts falling due within 1 year (185,988 ) 54,222 (131,766 )
Debts falling due after 1 year (1,828,056 ) 135,185 (1,692,871 )
(2,014,044 ) 189,407 (1,824,637 )
Total (1,939,087 ) 1,254,452 (684,635 )

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Nationwide Healthcare Providers Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises revenue recognised by the company in respect of dental services provided during the period and is recognised at the point the service is supplied.

Goodwill
Goodwill is the difference between amounts paid on the acquisitions of a business and the fair value of the identifiable assets and liabilities. It is amortised in the profit and loss account over its estimated useful life of 10 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Dental equipment - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 25% on reducing balance

The expected useful lives of assets are reviewed and adjusted, if appropriate, at the end of each
reporting period. The effect of any change is accounted for prospectively.

Stocks
Stocks are valued at the lower of cost and estimated selling price less costs to complete and sell, after making due allowance for obsolete and slow moving items.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS
31.3.25 31.3.24
£    £   
Wages and salaries 5,469,540 3,971,579
Social security costs 367,629 234,922
Other pension costs 56,419 37,380
5,893,588 4,243,881

The average number of employees during the year was as follows:
31.3.25 31.3.24

Directors 3 3
Other employees 269 213
272 216

31.3.25 31.3.24
£    £   
Directors' remuneration 73,200 73,200

4. OPERATING PROFIT

The operating profit is stated after charging:

31.3.25 31.3.24
£    £   
Other operating leases 478,045 487,736
Depreciation - owned assets 433,555 355,592
Goodwill amortisation 49,856 -
Auditors' remuneration 16,056 16,800

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. INTEREST PAYABLE AND SIMILAR EXPENSES
31.3.25 31.3.24
£    £   
Bank loan interest 130,520 67,501

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
31.3.25 31.3.24
£    £   
Current tax:
UK corporation tax 1,710,438 785,705
Corporation tax - prior year (1,471 ) -
Total current tax 1,708,967 785,705

Deferred tax 107,602 62,629
Tax on profit 1,816,569 848,334

UK corporation tax has been charged at 25% (2024 - 25%).

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

31.3.25 31.3.24
£    £   
Profit before tax 7,061,795 3,109,707
Profit multiplied by the standard rate of corporation tax in the UK of
25% (2024 - 25%)

1,765,449

777,427

Effects of:
Expenses not deductible for tax purposes 52,591 70,907
Adjustments to tax charge in respect of previous periods (1,471 ) -

Total tax charge 1,816,569 848,334

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

7. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024 20,020,821
Additions 156,891
At 31 March 2025 20,177,712
AMORTISATION
At 1 April 2024 19,522,262
Amortisation for year 49,856
At 31 March 2025 19,572,118
NET BOOK VALUE
At 31 March 2025 605,594
At 31 March 2024 498,559

8. TANGIBLE FIXED ASSETS
Fixtures
Freehold Dental and
property equipment fittings
£    £    £   
COST
At 1 April 2024 5,584,814 1,933,042 563,803
Additions 723,032 329,118 237,127
At 31 March 2025 6,307,846 2,262,160 800,930
DEPRECIATION
At 1 April 2024 285,971 871,419 440,487
Charge for year 110,009 208,774 54,066
At 31 March 2025 395,980 1,080,193 494,553
NET BOOK VALUE
At 31 March 2025 5,911,866 1,181,967 306,377
At 31 March 2024 5,298,843 1,061,623 123,316

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2024 191,306 266,022 8,538,987
Additions 52,500 62,816 1,404,593
At 31 March 2025 243,806 328,838 9,943,580
DEPRECIATION
At 1 April 2024 166,001 163,249 1,927,127
Charge for year 19,451 41,255 433,555
At 31 March 2025 185,452 204,504 2,360,682
NET BOOK VALUE
At 31 March 2025 58,354 124,334 7,582,898
At 31 March 2024 25,305 102,773 6,611,860

9. STOCKS
31.3.25 31.3.24
£    £   
Stocks 95,343 95,343

Stock recognised in cost of sales during the year as an expense was £1,934,157 (2024: £1,960,730)

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 2,237,942 1,401,429
Other debtors 27,293,786 22,977,842
Directors' current accounts 93,725 564,738
Corporation tax 15,480 15,480
Prepayments and accrued income 471,986 188,224
30,112,919 25,147,713

Included within other debtors are amounts due after 1 year of £898,130 (2024 - £1,073,435)

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans and overdrafts (see note 13) 131,766 196,755
Trade creditors 1,588,551 942,976
Corporation tax 1,163,661 154,694
Social security and other taxes 83,426 57,784
Other creditors 4,409,846 4,157,428
Accruals and deferred income 50,069 37,768
7,427,319 5,547,405

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

12. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.25 31.3.24
£    £   
Bank loans (see note 13) 1,692,871 1,828,056

13. LOANS

An analysis of the maturity of loans is given below:

31.3.25 31.3.24
£    £   
Amounts falling due within one year or on demand:
Bank overdrafts - 10,767
Bank loans 131,766 185,988
131,766 196,755

Amounts falling due between two and five years:
Bank loans - 2-5 years 560,192 625,490

Amounts falling due in more than five years:

Repayable by instalments
Bank loans > 5 years by instalments 1,132,679 1,202,566

Bank loans are repayable in instalments over 15 years and interest is charged at 1.9% over the Bank of England base rate.

14. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.3.25 31.3.24
£    £   
Within one year 471,400 440,400
Between one and five years 1,196,054 1,619,224
1,667,454 2,059,624

15. SECURED DEBTS

The following secured debts are included within creditors:

31.3.25 31.3.24
£    £   
Bank overdraft - 10,767
Bank loans 1,824,637 2,014,044
1,824,637 2,024,811

Bank loans and overdrafts are secured by fixed and floating charge over all assets of the company and guaranteed by related parties.

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

16. PROVISIONS FOR LIABILITIES
31.3.25 31.3.24
£    £   
Deferred tax
Accelerated capital allowances 323,784 217,065
Other timing differences - (883 )
323,784 216,182

Deferred
tax
£   
Balance at 1 April 2024 216,182
Charge to Income Statement during year 107,602
Balance at 31 March 2025 323,784

17. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.25 31.3.24
value: £    £   
10,000,000 Ordinary £1 10,000,000 10,000,000

Ordinary shares carry one vote per share and equal rights to dividends.

18. RESERVES
Retained
earnings
£   

At 1 April 2024 14,847,556
Profit for the year 5,245,226
At 31 March 2025 20,092,782

19. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
J Ahmad
Balance outstanding at start of year 564,738 -
Amounts advanced - 564,738
Amounts repaid (471,313 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 93,425 564,738

The loan is repayable upon demand and interest is charged at HMRC's official rate of interest.

20. RELATED PARTY DISCLOSURES

Nationwide Healthcare Providers Limited (Registered number: 07474135)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

20. RELATED PARTY DISCLOSURES - continued

Key management personnel of the entity or its parent (in the aggregate)
31.3.25 31.3.24
£    £   
Purchase of clinical services 201,859 199,220
Amount due from related party 93,725 564,738
Amount due to related party 30,432 31,338

Bank loans and overdrafts are secured by way of a personal guarantee from key management personnel.

Key management personnel are considered to be the directors of the company and their remuneration is disclosed in note 3.

Other related parties
31.3.25 31.3.24
£    £   
Rent paid 440,400 469,200
Interest received 68,647 71,372
Amount due from related party 27,278,255 18,929,229
Amount due to related party 2,692,294 4,318,826

Bank loans and overdrafts are secured by way of a guarantee from other related parties.

Other related parties are companies under common control.

21. ULTIMATE CONTROLLING PARTY

During the year the company was controlled by J Ahmad. At the date of approval of these financial statements there was no ultimate controlling party.